scholarly journals Cardiovascular Health Behaviors and Risk Factors Among Argentine and American University Students

Author(s):  
Gabriella Lynne Smith ◽  
Gina Fitzgerald ◽  
Don Thompson
2021 ◽  
Author(s):  
Jiao Liu ◽  
Weiming Tang ◽  
Yan Yang ◽  
Dan Luo ◽  
Na Zeng ◽  
...  

Abstract Background: Anxiety and depression in hypertensive patients may lead to poor blood pressure control and increases the risk of disease mortality. Lifestyle impacts depression and anxiety. This study aimed to assess cardiovascular health behaviors (CHBs) associated with co-morbid anxiety and depression among patients with hypertension.Methods: We included 488 hypertensive patients from Changsha, China. We measured anxiety and depression using the self-rating anxiety scale (SAS), and the self-rating depression scale (SDS), respectively. CHBs (smoking, overweight/obesity, leisure physical activity (LPA), and fruit and vegetable consumption (FVC)) were assessed using the Cardiovascular Health in Ambulatory Care Research Team (CANHEART) index. We compared anxiety and depression prevalence of participants in different socio-demographic, CHBs, co-morbidities, family histories, assessed risk factors and their biological synergistic interaction.Results: The proportion of not ideal in smoking, overweight/obesity, LPA, and FVC were 63.9%, 49.8%, 30.7%, 78.3%, respectively. Displaying comorbidity of HLP and not obtaining adequate amounts of LPA were risk factors for both anxiety and depression. The synergy interaction between obtaining secondary education or less and displaying comorbidity of hyperlipidemia (HLP) for anxiety (OR=5.238, 95% CI=2.784, 9.856), and between not obtaining adequate amounts of LPA and obtaining manual labor for depression (OR=7.164, 95% CI=3.553, 14.443) was statistically significant.Conclusion: Our study indicated that doctors should pay more attention to the psychiatric health of hypertensive patients at lower education levels and with second comorbidities. More importantly, patients with hypertension working on manual jobs need to pay closer attention to how they spend their leisure time and strengthen LPA.


2021 ◽  
Author(s):  
Jiao Liu ◽  
Weiming Tang ◽  
Yan Yang ◽  
Dan Luo ◽  
Na Zeng ◽  
...  

Abstract Background: Anxiety and depression in hypertensive patients may lead to poor blood pressure control and increases the risk of disease mortality. Lifestyle impacts depression and anxiety. This study aimed to assess cardiovascular health behaviors (CHBs) associated with co-morbid anxiety and depression among patients with hypertension.Methods: We included 488 hypertensive patients from Changsha, China. We measured anxiety and depression using the self-rating anxiety scale (SAS), and the self-rating depression scale (SDS), respectively. CHBs (smoking, overweight/obesity, leisure physical activity (LPA), and fruit and vegetable consumption (FVC)) were assessed using the Cardiovascular Health in Ambulatory Care Research Team (CANHEART) index. We compared anxiety and depression prevalence of participants in different socio-demographic, CHBs, co-morbidities, family histories, assessed risk factors and their biological synergistic interaction.Results: The proportion of not ideal in smoking, overweight/obesity, LPA, and FVC were 63.9%, 49.8%, 30.7%, 78.3%, respectively. Displaying comorbidity of HLP and not obtaining adequate amounts of LPA were risk factors for both anxiety and depression. The synergy interaction between obtaining secondary education or less and displaying comorbidity of hyperlipidemia (HLP) for anxiety (OR=5.238, 95% CI=2.784, 9.856), and between not obtaining adequate amounts of LPA and obtaining manual labor for depression (OR=7.164, 95% CI=3.553, 14.443) was statistically significant.Conclusion: Our study indicated that doctors should pay more attention to the psychiatric health of hypertensive patients at lower education levels and with second comorbidities. More importantly, patients with hypertension working on manual jobs need to pay closer attention to how they spend their leisure time and strengthen LPA.


Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Nour Makarem ◽  
Jacob Paul ◽  
Elsa-Grace Giardina ◽  
MING LIAO ◽  
Brooke Aggarwal

Background: Chronotype is the behavioral manifestation of an individual’s innate circadian rhythm. Evening chronotype (i.e. being a “night owl”) is linked to elevated chronic disease and mortality risk in European and Asian populations. Evidence from US cohorts is limited, particularly among women, in whom evening chronotype prevalence becomes higher from midlife onward, coinciding with life stages and hormonal changes associated with higher cardiovascular disease (CVD) risk. Hypothesis: Being a definite evening chronotype would be associated with poor cardiovascular health (CVH) and elevated cardiometabolic risk factors. Methods: Participants were 506 diverse women (mean age=37±16y, 62% racial/ethnic minority) in the AHA Go Red for Women Strategically Focused Research Network at Columbia University. Chronotype was measured using the Morningness-Eveningness Questionnaire (MEQ), the most widely used validated tool by circadian biologists to ascertain chronotype. Higher scores reflected greater morningness. Participants were also categorized as “evening” vs. “intermediate/morning” chronotypes based on their MEQ scores. Health behaviors (diet, physical activity, sleep, and sedentary time) were assessed using validated questionnaires. Health factors (BMI, blood pressure, fasting glucose, and cholesterol) were assessed at the clinic visit. Overall CVH was evaluated using the AHA Life’s Simple 7 (LS7) score (0-8: poor, 9-14: moderate to high). Linear and logistic regression models adjusted for age, race/ethnicity, education, health insurance, and menopause were used to examine associations of chronotype with CVH, clinical risk factors, and health behaviors. Results: Overall, 13% of women identified as being evening chronotypes. Higher MEQ scores (i.e. greater morningness) were associated with higher AHA LS7 scores (β=0.02, p=0.01), indicative of more favorable CVH. Higher MEQ scores were also associated with having a lower Pittsburgh Sleep Quality Index, i.e. better sleep quality, (β=-0.07, p<0.0001), a lower Insomnia Severity Index (β=-0.14, p<0.0001), shorter time to fall asleep (β=-0.28, p=0.04), and less sedentary time (β=-0.11, p=0.001). In contrast, being an evening chronotype was associated with higher odds of poor CVH (OR (95%CI): 2.41 (1.20-4.85)), not meeting AHA diet (OR (95%CI): 2.89 (1.59-5.23)) and physical activity guidelines, (OR (95%CI): 1.78 (1.03-3.07)), and having short sleep (<7h) (OR (95%CI): 2.15 (1.24-3.73)) or insomnia symptoms (OR (95%CI): 2.69 (1.53-4.75)). Conclusions: Women with evening chronotypes have greater odds of having poor CVH and adverse health behaviors after adjustment for sociodemographic factors and menopausal status. Chronotype may be important to consider and target in lifestyle interventions aimed at CVD prevention, particularly among middle-aged and older women who are prone to sleep changes.


2012 ◽  
Vol 82 (1) ◽  
pp. 41-52 ◽  
Author(s):  
P. Earnest ◽  
S. Kupper ◽  
M. Thompson ◽  
Guo ◽  
S. Church

Homocysteine (HCY), C-reactive protein (hsCRP), and triglycerides (TG) are risk factors for cardiovascular disease (CVD). While multivitamins (MVit) may reduce HCY and hsCRP, omega-3 fatty acids (N3) reduce TG; yet, they are seldom studied simultaneously. We randomly assigned 100 participants with baseline HCY (> 8.0 umol/L) to the daily ingestion of: (1) placebo, (2) MVit (VitC: 200 mg; VitE: 400 IU; VitB6: 25 mg; Folic Acid: 400 ug; VitB12: 400 ug) + placebo, (3) N3 (2 g N3, 760 mg EPA, 440 mg DHA)+placebo, or (4) MVit + N3 for 12 weeks. At follow-up, we observed significant reductions in HCY (umol/L) for the MVit (- 1.43, 95 %CI, - 2.39, - 0.47) and MVit + N3 groups (- 1.01, 95 %CI, - 1.98, - 0.04) groups, both being significant (p < 0.05) vs. placebo (- 0.57, 95 %CI, - 1.49, 0.35) and N3 (1.11, 95 % CI, 0.07, 2.17). hsCRP (nmol/L) was significantly reduced in the MVit (- 6.00, 95 %CI, - 1.04, - 0.15) and MVit + N3 (- 0.98, 95 %CI, - 1.51, - 0.46) groups, but not vs. placebo (- 0.15, 95 %CI, - 0.74, 0.43) or N3 (- 0.53, 95 %CI, - 1.18, 0.12). Lastly, we observed significant reductions in TG for the N3 (- 0.41, 95 %CI, - 0.69, - 0.13) and MVit + N3 (- 0.71, 95 %CI, - 0.93, - 0.46) groups, both significant vs. placebo (- 0.10, 95 %CI, - 0.36, 0.17) and MVit groups (0.15, 95 %CI, - 12, 0.42). The co-ingestion of MVit + N3 provides synergistic affects on HCY, hsCRP, and plasma TG.


2009 ◽  
Author(s):  
Caroline C. Piotrowski ◽  
Audrey Swift ◽  
Melanie Hegg ◽  
Alina Tablowski

2020 ◽  
Vol 4 (02) ◽  
pp. 104-110
Author(s):  
Fabiola B. Sozzi ◽  
Marta Belmonte ◽  
Marco Schiavone ◽  
Ciro Canetta ◽  
Rakesh Gupta ◽  
...  

AbstractAlthough substantial progress has been made toward improving gender- and sex-specific cardiovascular disease (CVD) management and outcomes, contemporary reports indicate a persistent knowledge gap with regard to optimal risk-stratification and management in female cardiac heart disease (CHD) patients. Prominent patient and system delays in diagnosing CHD are, in part, due to the limited awareness for the latent CVD risk in women, a lack of sex-specific thresholds within clinical guidelines, and subsequent limited performance of contemporary diagnostic approaches in women. Several traditional risk factors for CHD affect both women and men. But other factors can play a bigger role in the development of heart disease in women. In addition, little is known about the influence of socioenvironmental and contextual factors on gender-specific disease manifestation and outcomes. It is imperative that we understand the mechanisms that contribute to worsening risk factors profiles in young women to reduce future atherosclerotic CVD morbidity and mortality. This comprehensive review focuses on the novel aspects of cardiovascular health in women and sex differences as they relate to clinical practice and prevention, diagnosis, and treatment of CVD. Increased recognition of the prevalence of traditional cardiovascular risk factors and their differential impact in women, as well as emerging nontraditional risk factors unique to or more common in women, contribute to new understanding mechanisms, leading to worsening outcome for women.


Sign in / Sign up

Export Citation Format

Share Document